Omicron News and Research

RSS
Hybrid immunity from mRNA vaccines and breakthrough Omicron infections induces stronger immune responses against Omicron BQ.1.1

Hybrid immunity from mRNA vaccines and breakthrough Omicron infections induces stronger immune responses against Omicron BQ.1.1

High efficacy of SARS-CoV-2 vaccines in preventing COVID-19 deaths in children and adolescents

High efficacy of SARS-CoV-2 vaccines in preventing COVID-19 deaths in children and adolescents

Beta-containing COVID-19 booster vaccine found to cross-neutralize variants in non-human primates

Beta-containing COVID-19 booster vaccine found to cross-neutralize variants in non-human primates

Molnupiravir does not reduce hospitalization or deaths in vaccinated adults with COVID-19, but improves recovery

Molnupiravir does not reduce hospitalization or deaths in vaccinated adults with COVID-19, but improves recovery

Children less likely to transmit infectious particles, study finds

Children less likely to transmit infectious particles, study finds

COVID-19 vaccination protects people with B cell lymphoma and multiple myeloma

COVID-19 vaccination protects people with B cell lymphoma and multiple myeloma

Bivalent mRNA vaccine is moderately effective in preventing COVID-19

Bivalent mRNA vaccine is moderately effective in preventing COVID-19

T-cell immunity remains effective against SARS-CoV-2 Omicron subvariants

T-cell immunity remains effective against SARS-CoV-2 Omicron subvariants

Dutch study shows the effectiveness of COVID vaccination in reducing hospitalizations

Dutch study shows the effectiveness of COVID vaccination in reducing hospitalizations

Brazilian model for COVID-19 vaccination reduced severe case and mortality even from variants

Brazilian model for COVID-19 vaccination reduced severe case and mortality even from variants

Study: Long COVID has four major subtypes defined by different clusters of symptoms

Study: Long COVID has four major subtypes defined by different clusters of symptoms

Findings on the origins of the SARS-CoV-2 variant Omicron retracted

Findings on the origins of the SARS-CoV-2 variant Omicron retracted

Study finds several flavor/fragrance compositions that inhibit vRBD-hACE2 binding

Study finds several flavor/fragrance compositions that inhibit vRBD-hACE2 binding

Researchers generate a remodeled live-attenuated measles vaccine capable of driving nAb responses against SARS-CoV-2 spike protein

Researchers generate a remodeled live-attenuated measles vaccine capable of driving nAb responses against SARS-CoV-2 spike protein

The effectiveness of a bivalent COVID-19 mRNA booster dose against hospitalization

The effectiveness of a bivalent COVID-19 mRNA booster dose against hospitalization

Study identifies four new monoclonal antibodies with broad neutralizing potencies that target conserved SARS-CoV-2 epitopes

Study identifies four new monoclonal antibodies with broad neutralizing potencies that target conserved SARS-CoV-2 epitopes

Nasal antibodies decline nine months after COVID-19 infection, study finds

Nasal antibodies decline nine months after COVID-19 infection, study finds

Seasonal influenza activity remains high but appears to be declining in some areas of the US

Seasonal influenza activity remains high but appears to be declining in some areas of the US

Study demonstrates robust antibody response elicited by trivalent protein subunit vaccine against SARS-CoV-2

Study demonstrates robust antibody response elicited by trivalent protein subunit vaccine against SARS-CoV-2

Rise and waning of SARS-CoV-2 antibody responses induced by mRNA vaccine booster in a healthcare worker population

Rise and waning of SARS-CoV-2 antibody responses induced by mRNA vaccine booster in a healthcare worker population

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.